IP Verse

Pharmaceutical Compositions Comprising Aripiprazole - EP2051694

The patent EP2051694 was granted to Nobel Ilac Sanayi VE Ticaret on Oct 18, 2017. The application was originally filed on Aug 15, 2007 under application number EP07835588A. The patent is currently recorded with a legal status of "Revoked".

EP2051694

NOBEL ILAC SANAYI VE TICARET
Application Number
EP07835588A
Filing Date
Aug 15, 2007
Status
Revoked
Sep 4, 2020
Grant Date
Oct 18, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MULLENJul 6, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP1808164
INTERNATIONAL-SEARCH-REPORTEP1808165
INTERNATIONAL-SEARCH-REPORTUS2005019398
INTERNATIONAL-SEARCH-REPORTWO03030868
INTERNATIONAL-SEARCH-REPORTWO2005041937
INTERNATIONAL-SEARCH-REPORTWO2006097344
OPPOSITIONCN1709256
OPPOSITIONEP0367141
OPPOSITIONEP1808164
OPPOSITIONEP1808165
OPPOSITIONUS2005019398
OPPOSITIONWO03026659
OPPOSITIONWO03030868
OPPOSITIONWO2005041937
OPPOSITIONWO2006097344

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Cellulose, etc", Rowe R. C. et al, Handbook of Pharmaceutical Excipients. 5th ed., PhP, (20060000), pages 132-135,211-216,366,367-370,430 - 433,449-553,611-616,701-704,718-721,725-730, XP055512908-
OPPOSITION- "Chapter 18", Aulton M. E, Pharmaceutics: The Science of Dosage Form Design, (20050000), pages 304 - 320, XP055317802-
OPPOSITION- "Preformulation Testing", Lieberman H. A. et al, Pharmaceutical Dosage Forms. 2nd, rev. and exp., Marcel Dekker, pages 53 - 54, XP055512896-
OPPOSITION- Satoshi Aoki, et al, "Study on Crystal Transformation of ARIPIPRAZOL", 4th Japanese - Korean Symposium on Separation Technology, (19961006), pages 937 - 940, XP0002275111-
OPPOSITION- "Super Disintegrants", Swarbrick J. et al, Encyclopaedia of Pharmaceutical Technology, Marcel Dekker, (20010000), vol. 20, pages 269 - 294, XP055512903
OPPOSITION- GISSINGER D. et al, "A Comparative Evaluation of the Properties of some Tablet Disintegrants", Drug Development and Industrial Pharmacy, (19800000), vol. 6, no. 5, pages 511 - 536, XP008063508

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents